You are here: Home > For Researchers > Projects > Hercules III - PacBio RS - Sequencing with the PacBio RS system based on our single molecule, real-time (SMRT) technology

Hercules III - PacBio RS - Sequencing with the PacBio RS system based on our single molecule, real-time (SMRT) technology

From 01-03-2012 to 31-12-2016

Description

The PacBio RS system fills an important gap in the instrumentation that is necessary to address major scientific questions in genomics.   The PacBio RS is a third  -generation sequencing platform with Single Molecule Real Time technology (SMRT).  The sequencer introduces several new features to sequencing that are complementary with the current (second generation) sequencers that are available at the Genomics Core in Leuven and in other facilities in Flanders: It is the first instrument to detect DNA in real time. Moreover, no amplification step is required during sample preparation, because every sequence read derives from a single DNA molecule (single molecule sequencing). A further benefit is the long read length of more than 1,000 base pairs, which can currently only be achieved with conventional Sanger-based sequencing, but not by other high-throughput instruments. These long reads lead to a new quality in the sequence data for many applications.  The system will enable direct RNA and epigenome sequencing.  Finally, the application domains of PacBio RS go well beyond sequencing as the system has the capacity to measure the kinetics of DNA-protein interactions. 

Team

  • Diether Lambrechts, Co-promoter (External)
  • Stein Aerts, Co-promoter (External)
  • Yves Moreau, Co-promoter
  • Jan Cools, Co-promoter (External)
  • Joris Vermeesch, Promoter (External)

Financing

Funding: Vlaamse overheid - Vlaamse overheid

Program/Grant Type: Hercules - Zware en middlezware onderzoeksinfrastructuur

Events

2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery


3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery


12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers


More events

News

STADIUS Alumni Herman Verrelst – new CEO of Biocartis

08 June 2017

Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.


Supporting healthcare policymaking via machine learning – batteries included!

29 May 2017

STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.


Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"

10 February 2017

Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?


Joos Vandewalle is nieuwe voorzitter KVAB

09 October 2016

Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.


More news

Logo STADIUS